Cyclacel Pharmaceuti Stock Options

CYCC
 Stock
  

USD 0.81  0.03  3.57%   

Cyclacel Pharmaceuti's option chain provides insight into all available option contracts written on Cyclacel Pharmaceuti's stock. Investors can see outstanding put and call contracts with pricing information and greeks for a given expiration period. In addition, each of Cyclacel Pharmaceuti's stock options below provides a detailed picture of the payoff. Comparing vital and dynamic information of various option contracts across diverse expiration periods will help you make an educated decision on your market timing strategies around investing in a given Cyclacel option contract. View S&P 500 options
  
Purchasing Cyclacel Pharmaceuti options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Cyclacel calls. Remember, the seller must deliver Cyclacel Pharmaceuti stock to the call owner when a call is exercised.

In The Money vs. Out of Money Option Contracts on Cyclacel Pharmaceuti

Analyzing Cyclacel Pharmaceuti's in-the-money options over time can help investors to take a profitable long position in Cyclacel Pharmaceuti regardless of its overall volatility. This is especially true when Cyclacel Pharmaceuti's options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Cyclacel Pharmaceuti's options could be used as guardians of the underlying stock as they move almost dollar for dollar with Cyclacel Pharmaceuti's stock while costing only a fraction of its price.
Cyclacel Pharmaceuti's latest option contracts expiring on 2022-12-16 are carrying combined implied volatility of 0.0 with a put-to-call open interest ratio of 0.0 over 6 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on 2022-12-16. The current put volume is at 0, with calls trading at the volume of 1. This yields a 0.0 put-to-call volume ratio. The Cyclacel Pharmaceuti option chain provides detailed quote and price information for the current Cyclacel Pharmaceuti option contracts. It shows all of Cyclacel Pharmaceuti's listed puts, calls, expiration dates, strike prices, and other pricing information.
The chart above shows Cyclacel Pharmaceuti's distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Cyclacel Pharmaceuti's open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Cyclacel Pharmaceuti's option, there is no secondary market available for investors to trade.
Cyclacel Pharmaceuti's stock options are financial instruments that give investors the right to buy or sell shares of Cyclacel Pharmaceuti common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell Cyclacel stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If Cyclacel Pharmaceuti's stock price goes up or down, the stock options follow.
Continue to Trending Equities.
Please note that buying 'in-the-money' options on Cyclacel Pharmaceuti lessens the impact of time decay, as they carry both intrinsic and time value. So, even if Cyclacel Pharmaceuti's value remains static through the expiration date, the investor can sell to close an 'in-the-money' option to avoid a potential loss. However, in-the-money Cyclacel Pharmaceuti contracts are usually more expensive to enter than their out-of-the-money counterparts. So keep in mind that while the payoffs on an in-the-money trade can be high, the investors could ultimately experience a more consequential loss if Cyclacel Stock moves the wrong way.

Cyclacel Current Options Market Mood

Cyclacel Pharmaceuti's open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Cyclacel Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.

Put-to-Call Volume

Most options investors, including buyers and sellers of Cyclacel Pharmaceuti's calls and puts, are not very successful. It is estimated that an average options trader loses somewhere between 80% to 90% of the time. Cyclacel Pharmaceuti's option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction. Using current Cyclacel Pharmaceuti's option volume and open interest to make an investment decision is considered a contrarian-sentiment measure that can be utilized in many timing strategies in both derivative and spot marketplace.

Rule 16 of the current Cyclacel contract

Base on the Rule 16, the options market is currently suggesting that Cyclacel Pharmaceuti will have an average daily up or down price movement of about 0.0% per day over the life of the 2022-12-16 option contract. With Cyclacel Pharmaceuti trading at $0.81, that is roughly $0.0. If you think that the market is fully incorporating Cyclacel Pharmaceuti's daily price movement you should consider buying Cyclacel Pharmaceuti options at the current volatility level of 0.0%. But if you have an opposite viewpoint you should avoid it and even consider selling them.

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Cyclacel Pharmaceuti in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Cyclacel Pharmaceuti's short interest history, or implied volatility extrapolated from Cyclacel Pharmaceuti options trading.

Pair Trading with Cyclacel Pharmaceuti

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cyclacel Pharmaceuti position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cyclacel Pharmaceuti will appreciate offsetting losses from the drop in the long position's value.

Moving against Cyclacel Pharmaceuti

-0.69GEOGeo Group TrendingPairCorr
-0.67AZOAutozone Earnings Call  This WeekPairCorr
-0.58JPMJP Morgan Chase Fiscal Year End 13th of January 2023 PairCorr
-0.54APAApa Corp Potential GrowthPairCorr
The ability to find closely correlated positions to Cyclacel Pharmaceuti could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cyclacel Pharmaceuti when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cyclacel Pharmaceuti - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cyclacel Pharmaceuti to buy it.
The correlation of Cyclacel Pharmaceuti is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cyclacel Pharmaceuti moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cyclacel Pharmaceuti moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Cyclacel Pharmaceuti can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Continue to Trending Equities. Note that the Cyclacel Pharmaceuti information on this page should be used as a complementary analysis to other Cyclacel Pharmaceuti's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Complementary Tools for Cyclacel Stock analysis

When running Cyclacel Pharmaceuti price analysis, check to measure Cyclacel Pharmaceuti's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cyclacel Pharmaceuti is operating at the current time. Most of Cyclacel Pharmaceuti's value examination focuses on studying past and present price action to predict the probability of Cyclacel Pharmaceuti's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Cyclacel Pharmaceuti's price. Additionally, you may evaluate how the addition of Cyclacel Pharmaceuti to your portfolios can decrease your overall portfolio volatility.
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Is Cyclacel Pharmaceuti's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cyclacel Pharmaceuti. If investors know Cyclacel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cyclacel Pharmaceuti listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
10.6 M
Return On Assets
(0.42) 
Return On Equity
(0.60) 
The market value of Cyclacel Pharmaceuti is measured differently than its book value, which is the value of Cyclacel that is recorded on the company's balance sheet. Investors also form their own opinion of Cyclacel Pharmaceuti's value that differs from its market value or its book value, called intrinsic value, which is Cyclacel Pharmaceuti's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cyclacel Pharmaceuti's market value can be influenced by many factors that don't directly affect Cyclacel Pharmaceuti's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cyclacel Pharmaceuti's value and its price as these two are different measures arrived at by different means. Investors typically determine Cyclacel Pharmaceuti value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cyclacel Pharmaceuti's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.